Tomas M. Janssen

Position paper: how to treat more patients per professional without sacrificing job satisfaction and treatment quality.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: July 30, 2026

Safety and early organ preservation outcomes after dose escalation with MR-guided radiotherapy for rectal cancer (preRADAR): A phase I trial.

Journal: Clinical and translational radiation oncology

Published: March 19, 2026

Dose-based evaluation of delineation variation in radiotherapy: A scoping review.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: February 07, 2026

Automated prospective quality assurance of tumor segmentation and treatment planning in the hypo-FLAME 3.0 trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: January 30, 2026

Variability in manual editing of head and neck organs of interest auto-segmentations: a multi-user, longitudinal analysis.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: January 30, 2026

NTCP models predicting bowel toxicity after total neoadjuvant treatment or chemoradiation for rectal cancer in the RAPIDO trial.

Journal: International journal of radiation oncology, biology, physics

Published: November 26, 2025

Observation of tWZ Production at the CMS Experiment.

Journal: Physical review letters

Published: October 21, 2025

AID-RT: Standardising Artificial Intelligence Documentation in RadioTherapy with a domain-specific model card.

Journal: Physics and imaging in radiation oncology

Published: October 17, 2025

Direct-to-treatment MRI-guided prostate radiotherapy using a generic patient-agnostic reference plan.

Journal: Technical innovations & patient support in radiation oncology

Published: September 23, 2025

Are the CTV-to-PTV margins currently used in online adaptive radiotherapy for prostate cancer too large? The impact of the distribution of microscopic disease on treatment margin requirements.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: August 29, 2025

Position paper: how to treat more patients per professional without sacrificing job satisfaction and treatment quality.

Position paper: how to treat more patients per professional without sacrificing job satisfaction and treatment quality.

Safety and early organ preservation outcomes after dose escalation with MR-guided radiotherapy for rectal cancer (preRADAR): A phase I trial.

Safety and early organ preservation outcomes after dose escalation with MR-guided radiotherapy for rectal cancer (preRADAR): A phase I trial.

Dose-based evaluation of delineation variation in radiotherapy: A scoping review.

Dose-based evaluation of delineation variation in radiotherapy: A scoping review.

Automated prospective quality assurance of tumor segmentation and treatment planning in the hypo-FLAME 3.0 trial.

Automated prospective quality assurance of tumor segmentation and treatment planning in the hypo-FLAME 3.0 trial.

Variability in manual editing of head and neck organs of interest auto-segmentations: a multi-user, longitudinal analysis.

Variability in manual editing of head and neck organs of interest auto-segmentations: a multi-user, longitudinal analysis.

NTCP models predicting bowel toxicity after total neoadjuvant treatment or chemoradiation for rectal cancer in the RAPIDO trial.

NTCP models predicting bowel toxicity after total neoadjuvant treatment or chemoradiation for rectal cancer in the RAPIDO trial.

Observation of tWZ Production at the CMS Experiment.

Observation of tWZ Production at the CMS Experiment.

AID-RT: Standardising Artificial Intelligence Documentation in RadioTherapy with a domain-specific model card.

AID-RT: Standardising Artificial Intelligence Documentation in RadioTherapy with a domain-specific model card.

Direct-to-treatment MRI-guided prostate radiotherapy using a generic patient-agnostic reference plan.

Direct-to-treatment MRI-guided prostate radiotherapy using a generic patient-agnostic reference plan.

Are the CTV-to-PTV margins currently used in online adaptive radiotherapy for prostate cancer too large? The impact of the distribution of microscopic disease on treatment margin requirements.

Are the CTV-to-PTV margins currently used in online adaptive radiotherapy for prostate cancer too large? The impact of the distribution of microscopic disease on treatment margin requirements.

Semi-supervised learning in prostate MRI tumor detection approaches fully supervised performance on external validation.

Semi-supervised learning in prostate MRI tumor detection approaches fully supervised performance on external validation.

Primary Endpoint Analysis of the Phase 2 DESTINATION-MRL Trial for Patients With Intermediate-Risk Prostate Cancer.

Primary Endpoint Analysis of the Phase 2 DESTINATION-MRL Trial for Patients With Intermediate-Risk Prostate Cancer.